Azacitidine Combined With Chidamide in the Treatment of Newly Diagnosed PTCL Unfit for Conventional Chemotherapy
Clinical trial NCT04480125 · UNKNOWN
Trial details
- NCT number
- NCT04480125
- Sponsor
- Ruijin Hospital
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-06-20
- Primary completion
- 2022-06-20
- Enrollment
- 28
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.